| Institution: | 1. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran;2. Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran;3. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences;1. Coordinating Center for Clinical Trials, Division of Biostatistics, University of Texas School of Public Health, Houston, TX, USA;2. Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA;3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, USA;4. Preventive Medicine Section, Memphis Veterans Affairs Medical Center, Memphis, TN, USA;5. Jefferson Regional Medical Center, Jefferson Hills, PA, USA;6. Department of Medicine, University of California, Irvine, CA, USA;7. Cardiology Section, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA;8. Clinical Trials Service Unit, University of Washington, Seattle, WA, USA;9. Renal-Hypertension Section, Veterans Affairs New Jersey Health Care System, East Orange, NJ, USA;1. Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, Otwock, Poland;2. Department of Hematology, Jagiellonian University, Krakow, Poland;3. Department of Propedeutic Oncology, Medical University of Gdansk and Gdynia Oncology Center, Gdynia, Poland;4. Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland;5. Internal Medicine and Oncology Clinic, Silesian Medical University, Katowice, Poland;6. Department of Hematology, University of Medical Sciences, Poznan, Poland;1. Institute of Behavioral Sciences, University of Helsinki, Helsinki, Finland;2. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland;3. Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland;4. Helsinki University Central Hospital, Unit of General Practice, Helsinki, Finland;5. Folkhälsan Research Centre, Helsinki, Finland;6. Vasa Central Hospital, Vasa, Finland;7. Hospital for Children and Adolescents, Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland;8. Department of Obstetrics and Gynecology, Oulu University Hospital and University of Oulu, Oulu, Finland;1. Department of Obstetrics and Gynocology, Baskent University, Ankara, Turkey;2. Department of Cardiology, Baskent University, Ankara, Turkey;1. The Dudley Group NHS Foundation Trust, Dudley, UK;2. Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK;3. AstraZeneca Research and Development, Mölndal, Sweden;4. Przychodnia Neuromedyka, ?yrardów, Poland;5. SW Florida Clinical Research Center, Tampa, FL, USA;6. Former AstraZeneca Research and Development, Mölndal, Sweden;7. Institute of Rheumatology, Prague, Czech Republic;8. AstraZeneca Research and Development, Macclesfield, Cheshire East, UK;9. Brigham and Women''s Hospital, Boston, MA, USA;10. Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA |
